Lumos Diagnostics Holdings (ASX:LDX) LT-Debt-to-Total-Asset : 0.26 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Lumos Diagnostics Holdings's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.26.

Lumos Diagnostics Holdings's long-term debt to total assets ratio declined from Dec. 2023 (0.33) to Dec. 2024 (0.26). It may suggest that Lumos Diagnostics Holdings is progressively becoming less dependent on debt to grow their business.

Lumos Diagnostics Holdings LT-Debt-to-Total-Asset Historical Data

The historical data trend for Lumos Diagnostics Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumos Diagnostics Holdings LT-Debt-to-Total-Asset Chart

Lumos Diagnostics Holdings Annual Data

Trend

Jun22

Jun23

Jun24

LT-Debt-to-Total-Asset

0.17

0.31

0.27

Lumos Diagnostics Holdings Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial			0.17	0.31	0.33	0.27	0.26

Lumos Diagnostics Holdings LT-Debt-to-Total-Asset Calculation

Lumos Diagnostics Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (A: Jun. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Jun. 2024 )	/	Total Assets (A: Jun. 2024 )
	=	10.702	/	40.418
	=	0.26

Lumos Diagnostics Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	10.679	/	41.834
	=	0.26

Lumos Diagnostics Holdings (ASX:LDX) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Lumos Diagnostics Holdings LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Lumos Diagnostics Holdings's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Lumos Diagnostics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lumos Diagnostics Holdings Ltd (ASX:LDX) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

LDXHF:USA

Address

2724 Loker Avenue West, Carlsbad, CA, USA, 92010

Website

https://www.lumosdiagnostics.com

Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture, and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. The group is dedicated to providing contract research and development services, focusing on the innovation, development, manufacturing, and commercialization of point-of-care diagnostic solutions for both clinical and consumer applications. It generates maximum revenue from commercial services and solutions relating to POC diagnostic tests. The group has one operating segment, which is the provision of point-of-care diagnostics goods and services, and it operates across two geographical regions, the United States and Australia. and the majority of revenue is generated from the United States.

Lumos Diagnostics Holdings Headlines

No Headlines